Position in IBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$194,808
+$47,893 QoQ
Shares Held
111,319
+44.0% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 55 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. IBIO ranks #317 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in IBIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $194,808 | 111,319 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $146,915 | 77,324 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $77,806 | 40,314 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $19,126 | 23,044 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,513 | 23,044 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $92,636 | 23,044 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $24,904 | 10,165 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,566 | 10,165 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $21,448 | 10,165 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $5,327 | 17,757 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,831 | 17,757 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $36,934 | 17,757 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,545 | 14,876 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $63,231 | 371,951 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,707 | 371,951 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $768,389 | 1,786,953 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,046,021 | 1,901,858 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,054,264 | 1,937,986 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,023,464 | 2,002,295 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,371,324 | 2,189,173 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,052,013 | 1,954,299 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,774,882 | 874,327 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,549,416 | 697,936 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $68,699 | 64,811 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||